SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-24-001221
Filing Date
2024-03-14
Accepted
2024-03-14 16:29:13
Documents
16
Period of Report
2024-03-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K thct_8k.htm   iXBRL 8-K 22112
  Complete submission text file 0001477932-24-001221.txt   132857

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA thct-20240308.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20240308_lab.xml EX-101.LAB 12618
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20240308_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20240308_pre.xml EX-101.PRE 7881
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20240308_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT thct_8k_htm.xml XML 3424
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

IRS No.: 260164981 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55994 | Film No.: 24750611
SIC: 3523 Farm Machinery & Equipment
(CF Office: 06 Technology)